CD8A and viral infectious disease: Thus, at sites where NAD+ is released in large quantities from damaged cells, such as during a lytic viral infection, ADP-ribosylation of CD25 on Tregs would favor proliferation and function of CD8+ effector T cells, thereby enhancing pathogen eradication.